Posts Tagged ‘Oral Mucositis’

  • izunpharmaceuticals

    Expansion of Phase II Clinical Trial

    Izun Pharmaceuticals Corporation recently announced that it has expanded its ongoing Phase II clinical trial assessing the effect of its novel drug candidate, IZN-6N4, on Oral Mucositis (OM) to two additional medical centers, Memorial Sloan-Kettering Cancer Center and Beth Israel Medical Center, a component of the Continuum Cancer Centers of New York. The studies are

    Read More July 17, 2013